|
⚲
|
| Keyboard |
| Schwab Andrew J
✚
|
|
|---|---|
| CIK # | 0001598549 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001598549] | |
| 4 | [0001598549] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 35,000 | $0.00 | |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-11-14 | Sell | 200,000 | $8.80 | 1,760,000 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-07-09 | Sell | 20,065 | $7.50 | 150,488 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-07-09 | Sell | 6,935 | $7.50 | 52,012 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-07-01 | Sell | 6,422 | $7.12 | 45,725 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-07-01 | Sell | 18,578 | $7.12 | 132,275 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-06-30 | Sell | 18,578 | $6.81 | 126,516 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-06-30 | Sell | 6,422 | $6.81 | 43,734 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-06-27 | Sell | 55,735 | $6.91 | 385,129 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-06-27 | Sell | 19,265 | $6.91 | 133,121 |
|
Camp4 Therapeutics Corp CAMP
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2025-02-24 | Grant | 35,000 | $0.00 | |
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2024-10-28 | Grant | 70,000 | $0.00 | |
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 15,002,166 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 378,463 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 302,770 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 909,090 | $11.00 | 9,999,990 |
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 1,337,592 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 4,244,770 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 3,395,816 | ||
| showing 20 of 200 most recent transactions | |||||